Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 11;17(3):653-659.
doi: 10.1016/j.celrep.2016.09.050.

ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex

Affiliations

ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex

Richard T Timms et al. Cell Rep. .

Abstract

The histone methyltransferase SETDB1 plays a central role in repressive chromatin processes, but the functional requirement for its binding partner ATF7IP has remained enigmatic. Here, we show that ATF7IP is essential for SETDB1 stability: nuclear SETDB1 protein is degraded by the proteasome upon ablation of ATF7IP. As a result, ATF7IP is critical for repression that requires H3K9 trimethylation by SETDB1, including transgene silencing by the HUSH complex. Furthermore, we show that loss of ATF7IP phenocopies loss of SETDB1 in genome-wide assays. ATF7IP and SETDB1 knockout cells exhibit near-identical defects in the global deposition of H3K9me3, which results in similar dysregulation of the transcriptome. Overall, these data identify a critical functional role for ATF7IP in heterochromatin formation by regulating SETDB1 abundance in the nucleus.

Keywords: ATF7IP; H3K9me3; HUSH complex; SETDB1; epigenetic silencing; heterochromatin; histone methylation; ubiquitin-mediated degradation.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
The SETDB1-Interacting Protein ATF7IP Is Critical for HUSH-Mediated Epigenetic Repression (A–C) SETDB1 binds ATF7IP. Immunoprecipitation of SETDB1 from HeLa nuclear lysates followed by mass spectrometry (A) identified ATF7IP as the most significantly enriched co-immunoprecipitating protein (B); immunoprecipitation of ATF7IP also pulled down SETDB1 (C). (D) ATF7IP is critical for transgene silencing by the HUSH complex. CRISPR/Cas9-mediated disruption of ATF7IP resulted in the reactivation of a HUSH-repressed GFP reporter. (E) Depletion of ATF7IP results in reactivation of a silent GFP reporter construct. A HeLa clone harboring a HUSH-repressed GFP reporter was transduced with lentiviral vectors expressing either a control shRNA or shRNAs targeting ATF7IP, and derepression of the GFP reporter construct was assayed by flow cytometry. (F) Knockout of ATF7IP results in derepression of HUSH-repressed GFP reporter constructs in KBM7 cells. A polyclonal population of KBM7 cells harboring HUSH-repressed GFP reporter constructs was transduced sequentially with lentiviral vectors expressing Cas9 and single guide RNAs (sgRNAs) targeting ATF7IP, and depression of the GFP reporter constructs was monitored by flow cytometry. See also Figures S1 and S2.
Figure 2
Figure 2
ATF7IP Shields SETDB1 from Proteasomal Degradation in the Nucleus (A and B) Loss of ATF7IP abolishes the nuclear pool of SETDB1. The overall abundance of SETDB1 protein was not significantly affected in three independent ATF7IP knockout clones as assessed by immunoblot (A), but subcellular fractionation revealed a loss of SETDB1 from the nuclear fractions (B). (C) ATF7IP protects SETDB1 from proteasomal degradation in the nucleus. Treatment of ATF7IP knockout cells with the proteasome inhibitor bortezomib (20 nM for 40 hr) recovered SETDB1 levels in the nuclear fraction. (D and E) ATF7IP is destabilized in the absence of SETDB1. Loss of SETDB1 results in destabilization of ATF7IP (D), which can be recovered upon treatment with bortezomib (E). See also Figure S2.
Figure 3
Figure 3
H3K9me3 Loss across the Genome Is Similar upon Deletion of ATF7IP or SETDB1 (A–D) The distribution of H3K9me3 in wild-type, ATF7IP knockout, and SETDB1 knockout cells was assessed by ChIP-seq analysis. Three example loci are shown (A–C); near-identical profiles were observed in the ATF7IP and SETDB1 knockout cells (D). (E–H) Loss of ATF7IP and SETDB1 results in loss of H3K9me3 across zinc-finger genes. Validation of the ChIP-seq results by ChIP-qPCR at three example KRAB-ZNF gene loci (E). A near-total loss of H3K9me3 was observed across zinc-finger genes in the knockout cells (F and G), and the magnitude of this effect was similar in the ATF7IP and SETDB1 knockout samples (H). The error bars in (E) represent the SD of three qPCR technical replicates. See also Figures S3 and S4.
Figure 4
Figure 4
Deletion of ATF7IP Mirrors the Effect of SETDB1 Deletion on the Transcriptome (A) Schematic representation of the RNA-seq experiment. (B–E) Loss of ATF7IP and SETDB1 results in highly similar effects on the transcriptome. The colored dots represent genes exhibiting significantly altered expression (see Experimental Procedures) in ATF7IP knockout cells (green) or SETDB1 knockout cells (yellow) compared to wild-type cells (B and C); these genes are affected similarly in both knockout cells, because they lie in the center of the distribution when comparing ATF7IP knockout cells to SETDB1 knockout cells (D and E). See also Figure S4.

References

    1. Basavapathruni A., Gureasko J., Porter Scott M., Hermans W., Godbole A., Leland P.A., Boriack-Sjodin P.A., Wigle T.J., Copeland R.A., Riera T.V. Characterization of the enzymatic activity of SETDB1 and its 1:1 complex with ATF7IP. Biochemistry. 2016;55:1645–1651. - PubMed
    1. Becker J.S., Nicetto D., Zaret K.S. H3K9me3-dependent heterochromatin: barrier to cell fate changes. Trends Genet. 2016;32:29–41. - PMC - PubMed
    1. Ceol C.J., Houvras Y., Jane-Valbuena J., Bilodeau S., Orlando D.A., Battisti V., Fritsch L., Lin W.M., Hollmann T.J., Ferré F. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011;471:513–517. - PMC - PubMed
    1. Fei Q., Shang K., Zhang J., Chuai S., Kong D., Zhou T., Fu S., Liang Y., Li C., Chen Z. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53. Nat. Commun. 2015;6:8651. - PMC - PubMed
    1. Fujita N., Watanabe S., Ichimura T., Ohkuma Y., Chiba T., Saya H., Nakao M. MCAF mediates MBD1-dependent transcriptional repression. Mol. Cell. Biol. 2003;23:2834–2843. - PMC - PubMed

MeSH terms